Dr. Reddy's Laboratories, Inc. v. Celgene Corporation > Summary
Court Case Number IPR2018-01509
Filing Date Aug 3, 2018
Court Patent Trial and Appeal Board
Status Terminated-Denied
Administrative JudgesGrace Karaffa Obermann, Tina E. Hulse, Christopher G. Paulraj
Judge Writing the Final DecisionGrace Karaffa Obermann
Claims Challenged in the Petition: 1, 2, 3, 4, 5, 6, 11, 12, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34
Petitioner
Patent Owner
Petitioner Attorneys
5Dr. Reddy's Laboratories
Attorney Name: Brandon M. White
Perkins Coie
Dr. Reddy's Laboratories
Attorney Name: Emily J. Greb
Perkins Coie
Dr. Reddy's Laboratories
Attorney Name: Crystal R. Canterbury
Perkins Coie
Dr. Reddy's Laboratories
Attorney Name: Kenneth Anderson
Dr. Reddy's Laboratories
Dr. Reddy's Laboratories
Attorney Name: Marc R. Levin
Perkins Coie
Patent Owner Attorneys
8Celgene
Attorney Name: Frank C. Calvosa
Quinn Emanuel Urquhart & Sullivan
Celgene
Attorney Name: Andrew S. Chalson
Quinn Emanuel Urquhart & Sullivan
Celgene
Attorney Name: Matthew J. Hertko
Jones Day
Celgene
Attorney Name: Anthony M. Insogna
Jones Day
Celgene
Attorney Name: Christopher J. Harnett
Jones Day
Celgene
Attorney Name: Dominic Cerrito
Quinn Emanuel Urquhart & Sullivan
Celgene
Attorney Name: John Elsevier
Celgene
Celgene
Attorney Name: Cary Miller
Jones Day
Related Patents
| Doc No | Title | Issue date |
|---|---|---|
| 07189740 | Methods of using 3-(4-amino-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione for the treatment and management of myelodysplastic syndromes | Mar 13, 2007 |
